Testing for carcinogenicity of pharmaceuticals : S1, A ; Conditions which require carcinogenicity studies for pharmaceuticals S1, B ; Use of two rodent species S1, C ; Dose selection for carcinogenicity studies of pharmaceuticals

Journal of Toxicological Sciences

Volumn 21, Issue 5, 1996, Pages 475-478

  Usui, Toshimi ^a   Masuda, Hiroshi ^a  

^a Department of the Research and Development Division of Janssen Pharmaceutical KK in Tokyo   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENICITY; CONFERENCE PAPER; DIAGNOSTIC TEST; DOSE CALCULATION; DRUG INDUSTRY; PRACTICE GUIDELINE;

EID: 0030513450     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.21.5_475     Document Type: Article

References (3)

1. D'Arcy, P, F. and Harron, D, W, G, ; Proceedings of the Third International Conference on Harmonization. 1996, W, &G, Baird Ltd.
2. Fujii, K, ; Evaluation of the newborn mouse model for chemical tumorigenesis. 1991. Carcinogenesis, vol. 12 no. 8 pp, 1409-1415
3. International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Safety Topics S1,B. Testing for Carcinogenicity of Pharmaceuticals, Step 2 ,May 2 1996